Molecular diagnostic tests for hereditary cancers allow an early detection of genetic mutations that increase the risk of developing specific tumors. This information can also be used by oncologist for prevention or to design specific treatments.

  • Marco Pierotti

    Marco Alessandro Pierotti

    Head of CGT Lab & R&D Diagnostic and Scientific Director of BiLiGeCT project

    Accredited by National Health Service in Italy

    Our genetic testing facility is officially accredited by the Italian National Health Service (Servizio Sanitario Nazionale, SSN) and registered in the Regional Registry of Accredited Facilities at n.1118 on 31/08/2011 at the sub-branch of Cytogenetics and Medical Genetics for the performance of specialized laboratory Genetics and Molecular Biology.

  • Certifications and Quality controls

    Certified laboratory UNI EN ISO 9001:2015 n. IT256850


    Certified laboratory SIGUCERT n. 032


    External quality control

    EMQN 2021 | ISS 2020
    EMQN 2020 | ISS 2019
    EMQN 2019 | ISS 2018
    VEQ 2021
    VEQ 2019

  • Hospital affiliations

    If you are a doctor or a healthcare professional and you would like to have access to our genetic testing services through your hospital, contact us.


    Accredited laboratory UNI EN ISO 15189:2013



    AIRC logo